Cargando…

Pharmacists and Contraception in the Inpatient Setting

The choice of contraceptive method should be based on patient specific factors, patient preference, and method-specific properties. In this article, we review opportunities for an inpatient clinical pharmacist to assist in the selection and counseling of contraceptives in hospitalized patients. An i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciriello, Domenique, Cieri-Hutcherson, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356798/
https://www.ncbi.nlm.nih.gov/pubmed/32397460
http://dx.doi.org/10.3390/pharmacy8020082
_version_ 1783558565107073024
author Ciriello, Domenique
Cieri-Hutcherson, Nicole
author_facet Ciriello, Domenique
Cieri-Hutcherson, Nicole
author_sort Ciriello, Domenique
collection PubMed
description The choice of contraceptive method should be based on patient specific factors, patient preference, and method-specific properties. In this article, we review opportunities for an inpatient clinical pharmacist to assist in the selection and counseling of contraceptives in hospitalized patients. An inpatient pharmacist has the opportunity to discuss various contraceptive methods with the patient, ensuring an appropriate method is used after discharge, which is especially important after the occurrence of a contraception-related adverse effect or contraindication to certain contraceptive methods. Barriers, such as formulary restrictions, can limit inpatient initiation of contraceptive therapy while hospitalized, but pharmacists can provide education on appropriate alternatives. Inpatient clinical pharmacists can also make recommendations for contraceptive methods in special populations. It is crucial to select an appropriate therapy in patients with an underlying medical condition, such as those with active or history of breast cancer, psychiatric disorder, or thrombophilia, as inappropriate therapy can cause an increased risk of harm. Pharmacists can assist in contraceptive counseling, evaluating for drug-drug and drug-disease interactions, and recommending the most appropriate therapy in special populations. An inpatient pharmacist has the opportunity to interact with the medical team and assist in navigation of teratogenic medication use and Risk Evaluation and Mitigation Strategies.
format Online
Article
Text
id pubmed-7356798
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73567982020-07-22 Pharmacists and Contraception in the Inpatient Setting Ciriello, Domenique Cieri-Hutcherson, Nicole Pharmacy (Basel) Commentary The choice of contraceptive method should be based on patient specific factors, patient preference, and method-specific properties. In this article, we review opportunities for an inpatient clinical pharmacist to assist in the selection and counseling of contraceptives in hospitalized patients. An inpatient pharmacist has the opportunity to discuss various contraceptive methods with the patient, ensuring an appropriate method is used after discharge, which is especially important after the occurrence of a contraception-related adverse effect or contraindication to certain contraceptive methods. Barriers, such as formulary restrictions, can limit inpatient initiation of contraceptive therapy while hospitalized, but pharmacists can provide education on appropriate alternatives. Inpatient clinical pharmacists can also make recommendations for contraceptive methods in special populations. It is crucial to select an appropriate therapy in patients with an underlying medical condition, such as those with active or history of breast cancer, psychiatric disorder, or thrombophilia, as inappropriate therapy can cause an increased risk of harm. Pharmacists can assist in contraceptive counseling, evaluating for drug-drug and drug-disease interactions, and recommending the most appropriate therapy in special populations. An inpatient pharmacist has the opportunity to interact with the medical team and assist in navigation of teratogenic medication use and Risk Evaluation and Mitigation Strategies. MDPI 2020-05-09 /pmc/articles/PMC7356798/ /pubmed/32397460 http://dx.doi.org/10.3390/pharmacy8020082 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Ciriello, Domenique
Cieri-Hutcherson, Nicole
Pharmacists and Contraception in the Inpatient Setting
title Pharmacists and Contraception in the Inpatient Setting
title_full Pharmacists and Contraception in the Inpatient Setting
title_fullStr Pharmacists and Contraception in the Inpatient Setting
title_full_unstemmed Pharmacists and Contraception in the Inpatient Setting
title_short Pharmacists and Contraception in the Inpatient Setting
title_sort pharmacists and contraception in the inpatient setting
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356798/
https://www.ncbi.nlm.nih.gov/pubmed/32397460
http://dx.doi.org/10.3390/pharmacy8020082
work_keys_str_mv AT ciriellodomenique pharmacistsandcontraceptionintheinpatientsetting
AT cierihutchersonnicole pharmacistsandcontraceptionintheinpatientsetting